article
Claus Bendtsen at AstraZeneca reveals how AI can be used…
19 August 2019 | By Victoria Rees (Drug Target Review)
Claus Bendtsen at AstraZeneca reveals how AI can be used to improve our understanding of disease, to help identify the causes of conditions and aid in drug discovery.